These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

857 related items for PubMed ID: 23642578

  • 1. Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease.
    Teipel SJ, Grothe M, Lista S, Toschi N, Garaci FG, Hampel H.
    Med Clin North Am; 2013 May; 97(3):399-424. PubMed ID: 23642578
    [Abstract] [Full Text] [Related]

  • 2. Discriminative analysis of early-stage Alzheimer's disease and normal aging with automatic segmentation technique in subcortical gray matter structures: a multicenter in vivo MRI volumetric and DTI study.
    Li YD, He HJ, Dong HB, Feng XY, Xie GM, Zhang LJ.
    Acta Radiol; 2013 Dec; 54(10):1191-200. PubMed ID: 23878359
    [Abstract] [Full Text] [Related]

  • 3. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ, DeSanti S, Zinkowski R, Mehta PD, Pratico D, Segal S, Clark C, Kerkman D, DeBernardis J, Li J, Lair L, Reisberg B, Tsui W, Rusinek H.
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [Abstract] [Full Text] [Related]

  • 4. Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease.
    Doré V, Villemagne VL, Bourgeat P, Fripp J, Acosta O, Chetélat G, Zhou L, Martins R, Ellis KA, Masters CL, Ames D, Salvado O, Rowe CC.
    JAMA Neurol; 2013 Jul; 70(7):903-11. PubMed ID: 23712469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of Alzheimer disease risk by functional magnetic resonance imaging.
    Fleisher AS, Houston WS, Eyler LT, Frye S, Jenkins C, Thal LJ, Bondi MW.
    Arch Neurol; 2005 Dec; 62(12):1881-8. PubMed ID: 16344346
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vivo imaging of region and cell type specific neocortical neurodegeneration in Alzheimer's disease. Perspectives of MRI derived corpus callosum measurement for mapping disease progression and effects of therapy. Evidence from studies with MRI, EEG and PET.
    Hampel H, Teipel SJ, Alexander GE, Pogarell O, Rapoport SI, Möller HJ.
    J Neural Transm (Vienna); 2002 May; 109(5-6):837-55. PubMed ID: 12111472
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: a European multicenter study.
    Teipel SJ, Wegrzyn M, Meindl T, Frisoni G, Bokde AL, Fellgiebel A, Filippi M, Hampel H, Klöppel S, Hauenstein K, Ewers M, EDSD study group.
    J Alzheimers Dis; 2012 May; 31 Suppl 3():S33-47. PubMed ID: 22992380
    [Abstract] [Full Text] [Related]

  • 13. Parkinson's disease is associated with hippocampal atrophy.
    Camicioli R, Moore MM, Kinney A, Corbridge E, Glassberg K, Kaye JA.
    Mov Disord; 2003 Jul; 18(7):784-90. PubMed ID: 12815657
    [Abstract] [Full Text] [Related]

  • 14. Topography of cortical thinning areas associated with hippocampal atrophy (HA) in patients with Alzheimer's disease (AD).
    Kim GH, Jeon S, Seo SW, Kim MJ, Kim JH, Roh JH, Shin JS, Kim CH, Im K, Lee JM, Qiu A, Kim ST, Na DL.
    Arch Gerontol Geriatr; 2012 Jul; 54(2):e122-9. PubMed ID: 22088936
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW, Burton EJ, McKeith IG, Burn DJ, O'Brien JT.
    Neurology; 2005 Mar 08; 64(5):861-5. PubMed ID: 15753423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Basal Forebrain and Hippocampus as Predictors of Conversion to Alzheimer's Disease in Patients with Mild Cognitive Impairment - A Multicenter DTI and Volumetry Study.
    Brueggen K, Dyrba M, Barkhof F, Hausner L, Filippi M, Nestor PJ, Hauenstein K, Klöppel S, Grothe MJ, Kasper E, Teipel SJ.
    J Alzheimers Dis; 2015 Mar 08; 48(1):197-204. PubMed ID: 26401940
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Meta-analysis of CSF and MRI biomarkers for detecting preclinical Alzheimer's disease.
    Schmand B, Huizenga HM, van Gool WA.
    Psychol Med; 2010 Jan 08; 40(1):135-45. PubMed ID: 19863841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.